Lying on your back vs. your side: which is safer for kidney surgery?
NCT ID NCT07234409
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways to position patients during robot-assisted surgery to remove small kidney tumors. One group lies on their side (standard flank position), while the other lies on their back (supine position). The goal is to see which position leads to fewer complications, cleaner surgery, and faster recovery. The trial will include 124 adults with small kidney tumors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- robot-assisted partial nephrectomy (surgical procedure)
- What this could lead to
- If successful, this could show that the supine position is safer and less painful than the standard flank position for kidney tumor surgery.
- What could go wrong
- This is a small, early-stage trial with only 124 participants, so results may not apply to all patients. Both procedures are already used, so no major breakthrough is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 124 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* Age ≥ 18 years; * Presence of a single, unilateral, primary renal mass ≤ 7 cm in diameter (clinical stage cT1) documented CT scan * No evidence of systemic disease or lymph node involvement; * Candidate for robot-assisted partial nephrectomy using the Da Vinci SP platform; * Signed informed consent * Absence of solitary kidney status * No previous partial nephrectomy/ies on the same kidney * Absence of preoperative chronic kidney disease (CKD) stage 5 * Absence of any condition that makes mandatory or significantly more adequate the choice of a specific approach over the others (e.g., multiple previous major abdominal surgeries, horseshoe kidney, presence of stomas)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
ASST Grande Ospedale Metropolitano Niguarda
RECRUITINGMilan, 20162, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A camera that sees invisible light could guide kidney tumor removal
- Can a national registry reveal the secrets to better kidney surgery?
- AI may decode kidney tumors from MRI scans, avoiding biopsies
- 8,000 kidney tumor samples collected to unlock cancer clues
- New scan could help doctors choose best treatment for kidney tumors
- New drug combo aims to shrink kidney tumors before surgery